These are top 10 stocks traded on the Robinhood UK platform in July
On Monday, RBC Capital Markets adjusted its outlook on Avantor Inc . (NYSE:AVTR) by reducing the price target from $24.00 to $20.00, yet reaffirmed an Outperform rating on the company’s stock. The revision follows a significant drop in Avantor’s share value, which plummeted approximately 20% today, contributing to a 43% decline over the past six months. According to InvestingPro data, the stock is now trading near its 52-week low of $12.20, suggesting potential value for investors seeking opportunities in beaten-down stocks.
Conor McNamara of RBC Capital expressed a cautious stance on the immediate prospects for the sector, a sentiment previously indicated in the firm’s first quarter preview for 2025. McNamara raised several critical questions to justify the cautious perspective. He questioned whether new guidance from Avantor fully accounts for all current challenges and discussed the relevance of the company’s valuation amidst these uncertainties. Despite these concerns, InvestingPro analysis indicates the company maintains a GOOD overall financial health score, with particularly strong marks in profitability and relative value metrics.
Despite the near-term headwinds and today’s sharp decline in stock value, RBC Capital remains optimistic about Avantor’s long-term narrative. McNamara reiterated the Outperform rating, suggesting confidence in the company’s future, although the price target has been adjusted to reflect the immediate pressures faced by the company.
The report also provided insights into other companies within the sector, noting a positive read-through for Repligen Corporation (NASDAQ:RGEN) while indicating that risks persist for Thermo Fisher Scientific (NYSE:TMO), Bio-Techne Corporation (NASDAQ:TECH), and Illumina Inc. (NASDAQ:ILMN).
In summary, RBC Capital’s latest evaluation of Avantor underscores a belief in the company’s long-term potential despite acknowledging the current difficulties that have led to a reduction in the near-term price target.
In other recent news, Avantor Inc. reported its first-quarter 2025 earnings, revealing a revenue of $1.58 billion, which fell short of the anticipated $1.61 billion. The company managed to meet earnings per share (EPS) expectations with $0.23, despite these challenges. Avantor also announced plans to expand its cost transformation initiative, targeting $400 million in savings by 2027. Additionally, CEO Michael Stubblefield announced his intention to step down, prompting a search for his successor. In analyst updates, TD Cowen downgraded Avantor’s stock from Buy to Hold, reducing the price target to $15.50, citing concerns over growth prospects and market share losses. Morgan Stanley (NYSE:MS) also downgraded the stock from Overweight to Equalweight, lowering the price target to $15.00 due to competitive pressures and potential downside risks. Stifel followed suit, cutting the stock rating to Hold and slashing the price target to $14, after disappointing first-quarter results and a reduction in growth forecasts. These developments highlight the challenges Avantor faces in the current market environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.